BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $86 at Barclays
Tweet Send to a Friend
(Updated - October 4, 2024 7:52 AM EDT)
Barclays analyst Gena Wang lowered the price target on BioMarin Pharmaceutical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Gena Wang lowered the price target on BioMarin Pharmaceutical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
